Four main genetic pathways were identified that could explain 82% of relapses in adult B-ALL: IKZF1plus genetic profile, RAS mutations and TP53 alterations in Ph-negative B-ALL while ABL1 mutations were acquired at relapse in Ph-positive patients. Here, TP53 is linked to acute lymphoblastic leukemia.